Cited by 527Mitochondrial Function and PathologyCardiac Fibrosis and RemodelingNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure

Open access

Dai, Dao-Fu, Johnson, Simon C., Villarin, Jason J., Chin, Michael T., Nieves-Cintrón, Madeline, Chen, Tony, Marcinek, David J., Dorn, Gerald W., Kang, Y. James, Prolla, Tomas A., Santana, Luis F., Rabinovitch, Peter S.·2011·Circulation Research

DOI 10.1161/circresaha.110.232306PMC PMC3785241

Open this paper in CoChat — free account Open PDF

Abstract

Rationale: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. Objective: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes. Methods and Results: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II–treated mice. The causal role of mitochondrial ROS in angiotensin II–induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of Gαq. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase γ, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure. Conclusions: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.110.232306

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165
Self-citation
Extension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724
Self-citation
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
Mitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,672
Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Self-citation
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932

Show all 35 references

Sorted by citations

Items 301–400 of 526

LONP1 regulation of mitochondrial protein folding provides insight into beta cell failure in type 2 diabetes
Li, J., Deng, Y., Gasser, M., Zhu, J., Walker, E. M., Sidarala, V., Reck, E. C., Hubers, D. L., Pasmooij, M. B., Shin, C.-S., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01333-7 · Cited by 28
Dysregulated Redox Signaling and Its Impact on Inflammatory Pathways, Mitochondrial Dysfunction, Autophagy and Cardiovascular Diseases
Pervin, M., & de Haan, J. B. (2025) · Antioxidants · doi:10.3390/antiox14111278 · Cited by 28
Causes of upregulation of glycolysis in lymphocytes upon stimulation. A comparison with other cell types
Stark, H., Fichtner, M., König, R., Lorkowski, S., & Schuster, S. (2015) · Biochimie · doi:10.1016/j.biochi.2015.09.017 · Cited by 23
Mitochondrial Reversible Changes Determine Diastolic Function Adaptations During Myocardial (Reverse) Remodeling
Miranda‐Silva, D., Gonçalves‐Rodrigues, P., Alves, E. S., Rizo‐Roca, D., Fonseca, A. C. R. G., Lima, T., Baganha, F., Conceição, G., Sousa-Mendes, C., Gonçalves, A., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006170 · Cited by 23
The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential
Zhang, X., Zhang, Y., Sun, A., & Ge, J. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.04.001 · Cited by 24
The mTOR signaling pathway in cardiac aging
Dai, D., Kang, P., & Bai, H. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.10 · Cited by 24
Self-citation
Mechanism of Astragalus membranaceus (Huangqi, HQ ) for treatment of heart failure based on network pharmacology and molecular docking
Chen, Q., Wang, J., Sun, L., Ba, B., & Di-fei, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18331 · Cited by 23
Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease
Bigelman, E., Cohen, L., Aharon‐Hananel, G., Levy, R., Rozenbaum, Z., Saada, A., Keren, G., & Entin‐Meer, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198196 · Cited by 23
Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment
Reina‐Couto, M., Afonso, J., Carvalho, J., Morgado, L. A. R., Ronchi, F. A., Leite, A. P. D. O., Dias, C. C., Casarini, D. E., Bettencourt, P., Albino‐Teixeira, A., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110938 · Cited by 25
Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment
Huang, X., Hu, L., Long, Z., Wang, X., Wu, J., & Cai, J. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2503093 · Cited by 26
Skeletal muscle bioenergetics in aging and heart failure
Liu, S. Z., & Marcinek, D. J. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9586-z · Cited by 25
Self-citation
Dual Activity of Ginsenoside Rb1 in Hypertrophic Cardiomyocytes and Activated Macrophages: Implications for the Therapeutic Intervention of Cardiac Hypertrophy
Wang, S., Cui, Y., Xiong, M., Li, M., Wang, P., Cui, J., Du, X., Chen, Y., & Zhang, T. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s310633 · Cited by 22
Lipid Replacement Therapy: a Functional Food Approach with New Formulations for Reducing Cellular Oxidative Damage, Cancer-Associated Fatigue and the Adverse Effects of Cancer Therapy
Nicolson, G. L., & Settineri, R. A. (2011) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v1i4.134 · Cited by 23
Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy
Lee, C. Y., Park, H. K., Lee, B.-S., Jeong, S., Hyun, S., Choi, J., Kim, S. W., Lee, S., Lim, S., & Hwang, K. (2020) · Molecules · doi:10.3390/molecules25225279 · Cited by 21
Neurogenic Hypertension Mediated Mitochondrial Abnormality Leads to Cardiomyopathy: Contribution of UPRmt and Norepinephrine-miR- 18a-5p-HIF-1α Axis
Nandi, S. S., Katsurada, K., Mahata, S. K., & Patel, K. P. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.718982 · Cited by 22
Additive Amelioration of Oxidative Stress and Cardiac Function by Combined Mineralocorticoid and Angiotensin Receptor Blockers in Postinfarct Failing Hearts
Noda, K., Kobara, M., Hamada, J., Yoshifuji, Y., Shiraishi, T., Tanaka, T., Wang, J., Toba, H., & Nakata, T. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318258f8ce · Cited by 21
Metabolic effects of cardiovascular drugs
Fragasso, G., Margonato, A., Spoladore, R., & Lopaschuk, G. D. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.08.001 · Cited by 21
Autophagy in Ischemic Livers: A Critical Role of Sirtuin 1/Mitofusin 2 Axis in Autophagy Induction
Chun, S. K., Go, K. L., Yang, M., Zendejas, I. R., Behrns, K. E., & Js, K. (2016) · Toxicological Research · doi:10.5487/tr.2016.32.1.035 · Cited by 19
P-selectin increases angiotensin II-induced cardiac inflammation and fibrosis via platelet activation
Liu, G., Liang, B., Song, X., Bai, R., Qin, W., Sun, X., Lü, Y., Bian, Y., & XIAO, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5186 · Cited by 20
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
Zheng, C., Xuan, W., Chen, Z., Zhang, R., Huang, X., Zhu, Y., Ma, S., Chen, K., Chen, L., He, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.848310 · Cited by 20
Metabolic enzymes dysregulation in heart failure: the prospective therapy
Parihar, P., & Parihar, M. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9588-x · Cited by 16
Nanoparticles for Postinfarct Ventricular Remodeling
Dong, C., Ma, A., & Shang, L. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0264 · Cited by 20
Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline
Pacagnelli, F. L., Sabela, A. K. D. D. A., Okoshi, K., Mariano, T. B., de Campos, D. H. S., Carvalho, R. F., Cicogna, A. C., & Vanderlei, L. C. M. (2016) · International Journal of Experimental Pathology · doi:10.1111/iep.12166 · Cited by 20
Propofol Protects Lung Endothelial Barrier Function by Suppression of High-Mobility Group Box 1 (HMGB1) Release and Mitochondrial Oxidative Damage Catalyzed by HMGB1
Feng, Z., Wang, J., Wang, Y., Dong, W., & Xu, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.915417 · Cited by 19
TRPV1 Suppressed NLRP3 Through Regulating Autophagy in Microglia After Ischemia-Reperfusion Injury
Lin, Y., Huang, T., Shen, W., Pang, Q., Xie, Q., Chen, X., & Tu, F. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01935-2 · Cited by 19
Angiotensin II Influences Pre-mRNA Splicing Regulation by Enhancing RBM20 Transcription Through Activation of the MAPK/ELK1 Signaling Pathway
Cai, H., Zhu, C., Chen, Z., Rexiati, M., Sun, M., McCormick, R. J., Lan, X., Chen, H., & Guo, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205059 · Cited by 19
Thiopental sodium loaded solid lipid nano-particles attenuates obesity-induced cardiac dysfunction and cardiac hypertrophy via inactivation of inflammatory pathway
Zhu, C., Li, W., Wang, X., Xue, J., Zhao, L., Song, Y., Zhou, T. G., & Zhang, M. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1803449 · Cited by 19
Cardioprotective effect of ultrasound‐targeted destruction of Sirt3‐loaded cationic microbubbles in a large animal model of pathological cardiac hypertrophy
Qin, X., Cai, P., Liu, C., Chen, K., Jiang, X., Chen, W., Li, J., Jiao, X., Guo, E., Yu, Y., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.04.020 · Cited by 18
“Unravelling the impacts of climatic heat events on cardiovascular health in animal models”
Mol, N., Priya, A., Singh, A. K., Mago, P., Shalimar, S., & Ray, A. K. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118315 · Cited by 18
Overexpression of Mitofilin in the Mouse Heart Promotes Cardiac Hypertrophy in Response to Hypertrophic Stimuli
Zhang, Y., Xu, J., Luo, Y., An, X., Zhang, R., Liu, G., Li, H., Chen, H., & Liu, D. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5438 · Cited by 18
Mitochondrial Dysfunction-Associated Arrhythmogenic Substrates in Diabetes Mellitus
Song, J., Yang, R., Yang, J., & Zhou, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01670 · Cited by 18
Role of circulating factors in cardiac aging
Cannata, A. N., Marcon, G., Cimmino, G., Camparini, L., Ciucci, G., Sinagra, G., & Loffredo, F. S. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.03.95 · Cited by 20
Mechanism of ferroptosis in heart failure: The role of the RAGE/TLR4-JNK1/2 pathway in cardiomyocyte ferroptosis and intervention strategies
Zhang, Z., Yang, Z., Wang, S., Wang, X., & Mao, J. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102770 · Cited by 18
Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy
Xu, A., Weissman, D., Ermer, K. J., Bertero, E., Federspiel, J. M., Stadler, F., Grünler, E., Tangos, M., Zervou, S., Waddingham, M. T., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.074120 · Cited by 17
Hypertrophied myocardium is vulnerable to ischemia/reperfusion injury and refractory to rapamycin-induced protection due to increased oxidative/nitrative stress
Ma, L., Li, Y., Yin, P., Kong, F., Guo, J., Shi, H., Zhu, J., Zou, Y., & Ge, J. (2017) · Clinical Science · doi:10.1042/cs20171471 · Cited by 18
Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy
Xu, D., Zhao, Y., Weng, X., Lu, Y., Li, W., Tang, K., Chen, W., Liu, Z., Qi, X., Zheng, J., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.025 · Cited by 17
An overview of alamadine/MrgD signaling and its role in cardiomyocytes
de Jesus, I. C. G., Mesquita, T., Santos, R. A. S., & Guatimosim, S. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00399.2021 · Cited by 17
Cognitive impairment in patients with heart failure: molecular mechanism and therapy
Wu, Y., Chen, L., Zhong, F., Zhou, K., Lu, C., Cheng, X., & Wang, S. (2023) · Heart Failure Reviews · doi:10.1007/s10741-022-10289-9 · Cited by 20
Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension
Liao, X., Han, Y., He, Y., Liu, J., & Wang, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1209890 · Cited by 21
Mechanism of fibroblast growth factor 21 in cardiac remodeling
Zhao, Z., Cui, X., & Liao, Z. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1202730 · Cited by 18
Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure
Dai, D., Liu, Y., Basisty, N., Karunadharma, P. P., Dastidar, S. G., Chiao, Y. A., Chen, T., Beyer, R. P., Chin, M. T., MacCoss, M. J., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00119-6 · Cited by 17
Self-citation
Mitoprotective antioxidant EUK-134 stimulates fatty acid oxidation and prevents hypertrophy in H9C2 cells
Purushothaman, S., & Nair, R. R. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2788-9 · Cited by 17
Natural products and ferroptosis: A novel approach for heart failure management
Zhang, Z., Yang, Z., Wang, S., Wang, X., & Mao, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156783 · Cited by 17
Mitochondrial DNA Dysfunction in Cardiovascular Diseases: A Novel Therapeutic Target
Xiang, M., Yang, M., Zhang, L., Ouyang, X., Sarapultsev, A., Luo, S., & Hu, D. (2025) · Antioxidants · doi:10.3390/antiox14091138 · Cited by 17
Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review
Hung, M., Yeh, C., Kounis, N. G., Koniari, I. C., Hu, P., & Hung, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087530 · Cited by 17
Metabolic Approaches for the Treatment of Dilated Cardiomyopathy
Spoladore, R., Pinto, G., Daus, F., Pezzini, S., Kolios, D., & Fragasso, G. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10070287 · Cited by 16
Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function
McDermott‐Roe, C., Leleu, M., Rowe, G. C., Palygin, O., Bukowy, J. D., Kuo, J., Rech, M., Hermans-Beijnsberger, S., Schaefer, S., Adami, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170458 · Cited by 15
Cardiovascular Disease and Aging
Chiao, Y. A., Lakatta, E. G., Ungvari, Z. I., Dai, D., & Rabinovitch, P. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_5 · Cited by 16
Self-citation
PTSD as an Endothelial Disease: Insights From COVID-19
Sfera, A., Osorio, C. P., Rahman, L., del Campo, C. M. Z.-M., Maldonado, J. C., Jafri, N., Cummings, M. A., Maurer, S., & Kozlakidis, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.770387 · Cited by 16
Long noncoding RNAs in cardiometabolic disorders
Juni, R. P., Hart, K. C. ‘., Houtkooper, R. H., & Boon, R. A. (2022) · FEBS Letters · doi:10.1002/1873-3468.14370 · Cited by 16
The dual effects of autophagy in myocardial hypertrophy
Li, J., & Cai, Y. (2015) · Acta cardiologica. Supplementum · doi:10.1080/ac.70.4.3096899 · Cited by 16
Identification of the Mtus1 Splice Variant as a Novel Inhibitory Factor Against Cardiac Hypertrophy
Ito, S., Asakura, M., Liao, Y., Min, K., Takahashi, A., Shindo, K., Yamazaki, S., Tsukamoto, O., Asanuma, H., Mogi, M., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003521 · Cited by 16
Centella asiatica (L.) Urb. Prevents Hypertension and Protects the Heart in Chronic Nitric Oxide Deficiency Rat Model
Bunaim, M. K., Kamisah, Y., Mustazil, M. N. M., Zuhair, J. S. F., Juliana, A. H., & Muhammad, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.742562 · Cited by 26
Mitochondrial quality control: Biochemical mechanism of cardiovascular disease
Inferrera, F., Marino, Y., Genovese, T., Cuzzocrea, S., Fusco, R., & Paola, R. D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119906 · Cited by 16
c‑Jun/Ap‑1 is upregulated in an Ang II‑induced abdominal aortic aneurysm formation model and mediates Chop expression in mouse aortic smooth muscle cells
Sun, D., Zhang, M., Li, Y., Mei, S., Jin, Q., & Yan, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10017 · Cited by 15
Sulfated N-acetylglucosamino-glucuronopyranosyl-arabinopyranan from seafood Amphioctopus neglectus attenuates angiotensin-II prompted cardiac hypertrophy
Chakraborty, K., Krishnan, S., & Joy, M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.037 · Cited by 15
High-Density Lipoprotein-Targeted Therapies for Heart Failure
Mishra, M., & Geest, B. D. (2020) · Biomedicines · doi:10.3390/biomedicines8120620 · Cited by 15
The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
Priddy, C. N., & Li, J. (2021) · Bone Reports · doi:10.1016/j.bonr.2021.101149 · Cited by 15
Junctophilin 2 knockdown interfere with mitochondrium status in ESC‐CMs and cardiogenesis of ES cells
Liang, X., Mei, Y., Huang, X., Shen, G., Zhu, D., Yu, Y., Wang, J., & Lou, Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24164 · Cited by 15
Angiotensin II-induced mitochondrial reactive oxygen species and peroxiredoxin-3 expression in cardiac fibroblasts
Lijnen, P. J., Piccart, Y., Coenen, T., & Prihadi, J. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835726c1 · Cited by 15
Renovascular Hypertension Induces Myocardial Mitochondrial Damage, Contributing to Cardiac Injury and Dysfunction in Pigs With Metabolic Syndrome
Nargesi, A. A., Farah, M. C., Zhu, X.-Y., Zhang, L., Tang, H. J., Jordan, K. L., Saadiq, I. M., Lerman, A., Lerman, L. O., & Eirin, A. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa202 · Cited by 17
Thymosin β4 Prevents Angiotensin II-Induced Cardiomyocyte Growth by Regulating Wnt/WISP Signaling
Li, L., Guleria, R. S., Thakur, S., Zhang, C., Pan, J., Baker, K. M., & Gupta, S. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25275 · Cited by 14
Single-Stranded DNA-Binding Protein 1 Abrogates Cardiac Fibroblast Proliferation and Collagen Expression Induced by Angiotensin II
Tian, H., Sun, Y., He, L., Yi, Y.-F., Gao, X., & Xu, D. (2018) · International Heart Journal · doi:10.1536/ihj.17-650 · Cited by 14
Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway
Zhao, Z., Liu, H., Li, Y., Tian, J., & Deng, S. (2020) · Medical Science Monitor · doi:10.12659/msm.923025 · Cited by 14
Retracted
Pharmacological anti-remodelling effects of disease-modifying drugs in heart failure with reduced ejection fraction
Correale, M., Mazzeo, P., Tricarico, L., Croella, F., Fortunato, M., Magnesa, M., Amatruda, M., Alfieri, S., Ferrara, S., Ceci, V., et al. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01166-2 · Cited by 14
Mitochondrial Oxidative Stress Mediates Bradyarrhythmia in Leigh Syndrome Mitochondrial Disease Mice
Chen, B., Daneshgar, N., Lee, H., Song, L., & Dai, D. (2023) · Antioxidants · doi:10.3390/antiox12051001 · Cited by 14
Self-citation
Reduced Expression of UPRmt Proteins HSP10, HSP60, HTRA2, OMA1, SPG7, and YME1L Is Associated with Accelerated Heart Failure in Humans
Baković, P., Mirošević, V., Svaguša, T., Šepac, A., Kulić, A., Miličić, D., Gašparović, H., Rudež, I., Urlić, M., Sikirić, S., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051142 · Cited by 14
Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation
Rutledge, C. A., Enriquez, A., Redding, K., Lopez, M. A., Mullett, S. J., Gelhaus, S. L., Jurczak, M. J., Goetzman, E. S., & Kaufman, B. A. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07482-9 · Cited by 13
Cardioprotective Effect of the Selective Sigma-1 Receptor Agonist, SA4503
Hirano, K., Tagashira, H., & Fukunaga, K. (2014) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.13-00255-3 · Cited by 13
Allyl Methyl Sulfide Preserved Pressure Overload-Induced Heart Failure Via Modulation of Mitochondrial Function
Mohammed, S. A., Bugga, P., Meghwani, H., Reddy, M. P. K., Arava, S. K., & Banerjee, S. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111316 · Cited by 13
Class I HDAC modulates angiotensin II–induced fibroblast migration and mitochondrial overactivity
Huynh, T. V., Rethi, L., Chung, C., Yeh, Y., Kao, Y., & Chen, Y. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13712 · Cited by 13
Protein tyrosine phosphatase 1B regulates miR-208b-argonaute 2 association and thyroid hormone responsiveness in cardiac hypertrophy
Coulis, G., Londhe, A. D., Sagabala, R. S., Shi, Y., Labbé, D. P., Bergeron, A., Sahadevan, P., Nawaito, S. A., Sahmi, F., Josse, M., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abn6875 · Cited by 13
Salivary lipid mediators: Key indexes of inflammation regulation in heart failure disease
Biagini, D., Ghimenti, S., Lenzi, A., Bonini, A., Vivaldi, F. M., Oger, C., Galano, J., Balas, L., Durand, T., Salvo, P., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.015 · Cited by 13
Reactive Oxygen Species and the Cardiovascular System
Montezano, A. C. I., & Touyz, R. M. (2012) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00043ed1v01y201112isp032 · Cited by 14
Triheptanoin Alleviates Ventricular Hypertrophy and Improves Myocardial Glucose Oxidation in Rats With Pressure Overload
Nguyễn, T. D., Shingu, Y., Amorim, P., Schwarzer, M., & Doenst, T. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.07.009 · Cited by 14
Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy
Sharma, B., Chaube, U., & Patel, B. M. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-018-9470-2 · Cited by 13
Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1s/sα2s/s Mouse Model of High Affinity for Cardiotonic Steroids
Marck, P. V., Pessoa, M. T., Xu, Y., Kutz, L. C., Collins, D. M., Yan, Y., King, C., Wang, X., Duan, Q., Cai, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073462 · Cited by 13
Excess sarcoplasmic reticulum-mitochondria calcium transport induced by Sphingosine-1-phosphate contributes to cardiomyocyte hypertrophy
Qi, Y. X., Li, J.-J., Di, X., Zhang, Y., Chen, J.-L., Wu, Z.-X., Man, Z., Bai, R., Lu, F., Tong, J., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118970 · Cited by 12
Targeting Mitochondrial Metabolism to Save the Failing Heart
Schenkl, C., Heyne, E., Doenst, T., Schulze, P. C., & Nguyễn, T. D. (2023) · Life · doi:10.3390/life13041027 · Cited by 12
La interacción vitamina D-mitocondria podría modular el camino de señalización involucrado en el desarrollo de la hipertensión: una visión integrativa translacional
Sanz, R. L., Mazzei, L. J., Santino, N., Ingrasia, M., & Manucha, W. A. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.02.002 · Cited by 12
Effects of chronic intermittent hypoxia on left cardiac function in young and aged mice
Qin, W. D., Xu, X., Chen, L., Wang, T., Xie, L., Yu, F., Song, S.-F., Sheng, Z.-Q., & Tong, J. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00256.2021 · Cited by 12
Mitochondrial reactive oxygen species cause arrhythmias in hypertrophic cardiomyopathyPreprint
Kohlhaas, M., Sequeira, V., Parikh, S. S., Dietl, A., Richter, O., Bay, J., Bertero, E., Schwemmlein, J., Tian, X. Y., Friedrich, F. W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.02.616214 · Cited by 12
From complexity to clarity: aging bone marrow niche in bone and blood regeneration and malignancy
Roy, N., Liu, H., Horenberg, A. L., Pathak, A. P., Chen, J., Ramasamy, S. K., Cohen-Solal, M. E., Bözec, A., Grayson, W. L., & Kusumbe, A. P. (2026) · Bone Research · doi:10.1038/s41413-026-00543-3 · Cited by 11
ADP-ribosylation: An emerging direction for disease treatment
Liu, Y., Che, Y., Qiu, H.-L., Xia, H., Feng, Y.-Z., Deng, J.-Y., Yuan, Y., & Tang, Q. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102176 · Cited by 13
Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review
Dabbaghi, M. M., Roudi, H. S., Safaei, R., Rahimi, V. B., Fadaei, M. R., & Askari, V. R. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09921-x · Cited by 11
Mitochondria‑derived peptides: Promising microproteins in cardiovascular diseases (Review)
Ran, Y., Guo, Z.-L., Zhang, L., Li, H., Zhang, X.-Y., Guan, X.-M., Cui, X.-D., Chen, H., & Cheng, M. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13492 · Cited by 11
Interaction between mitochondrial oxidative stress and myocardial fibrosis in the context of diabetes
Zhang, P., Li, N.-N., Gu, X. Q., Zhou, C., Jiang, Z.-Z., Luo, X.-J., Zhu, H., & Zhu, X.-Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1596436 · Cited by 11
Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide
Yang, R., Tan, X. L., Ge, L.-J., Sun, J., Peng, X.-D., & Wang, W. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.09.002 · Cited by 11
Ciliary neurotrophic factor overexpression protects the heart against pathological remodelling in angiotensin II-infused mice
Zhong, P., Zeng, G., Lei, C., Tian, G.-P., Ouyang, S., Liu, F., & Peng, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.01.111 · Cited by 11
A Diet High in Fat and Fructose Induces Early Hepatic Mitochondrial Aging
Bramlage, K., Bhattacharjee, J., Kirby, M., Myronovych, A., Gupta, R., Salazar-Gonzalez, R.-M., Xanthakos, S. A., Bove, K. E., & Kohli, R. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003068 · Cited by 11
The Correlation of PPARαActivity and Cardiomyocyte Metabolism and Structure in Idiopathic Dilated Cardiomyopathy during Heart Failure Progression
Czarnowska, E., Domal-Kwiatkowska, D., Reichman-Warmusz, E., Bierła, J. B., Sowińska, A., Ratajska, A., Góral, K., & Wojnicz, R. (2016) · PPAR Research · doi:10.1155/2016/7508026 · Cited by 11
RETRACTED: Mitochondrial tRNA Mutations Associated With Essential Hypertension: From Molecular Genetics to Function
Liu, Y., & Chen, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.634137 · Cited by 11
Retracted
Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus
Szczepanska‐Sadowska, E. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021310 · Cited by 10
Mitochondrial complex-1 as a therapeutic target for cardiac diseases
Rai, N. K., Venugopal, H., Rajesh, R., Ancha, P., & Venkatesh, S. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05074-1 · Cited by 12
An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress
Sorge, M., Savoré, G., Gallo, A., Acquarone, D., Sbroggió, M., Velasco, S., Zamporlini, F., Femminò, S., Moiso, E., Morciano, G., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00132-z · Cited by 11
Evaluating sex-specific responses to western diet across the lifespan: impact on cardiac function and transcriptomic signatures in C57BL/6J mice at 530 and 640/750 days of age
Stepanyan, A., Brojakowska, A., Zakharyan, R., Hakobyan, S., Davitavyan, S., Sirunyan, T., Khachatryan, G., Khlgatian, M. K., Bisserier, M., Zhang, S., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02565-9 · Cited by 10
Cardiac-specific overexpression of serum response factor regulates age-associated decline in mitochondrial function
Patyal, P., Azhar, G., Zhang, X., Verma, A., & Wei, J. Y. (2025) · GeroScience · doi:10.1007/s11357-025-01629-2 · Cited by 12
Vascular injury associated with ethanol intake is driven by AT1 receptor and mitochondrial dysfunction
Awata, W. M. C., Alves, J. V., da Costa, R. M., Bruder‐Nascimento, A., Singh, S., Barbosa, G. S., Tirapelli, C. R., & Bruder-Nascimento, T. B. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115845 · Cited by 10
Non-coding RNAs and Cardiac Aging
Zhao, C., Li, G., & Li, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_14 · Cited by 11
Hibiscus sabdariffa Linn. (Roselle) Polyphenols-Rich Extract Prevents Hyperglycemia-Induced Cardiac Oxidative Stress and Mitochondrial Damage in Diabetic Rats
Yusof, N. L. M., Affendi, T. N. T. T., Jubaidi, F. F., Zainalabidin, S., & Budin, S. B. (2020) · Sains Malaysiana · doi:10.17576/jsm-2020-4910-15 · Cited by 10

Authors: Dai, D.-F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., Kang, Y. J., Prolla, T. A., Santana, L. F., & Rabinovitch, P. S.
Affiliations: University of Louisville (US)
From the Departments of Pathology (D.-F.D., S.C.J., T.C., P.S.R.), Radiology (J.J.V., D.J.M.), Cardiovascular Medicine (M.T.C.), Physiology and Biophysics (M.N.-C., L.F.S.), University of Washington, Seattle; Department of Internal Medicine (G.W.D.), Washington University School of Medicine, St Louis, MO; Departments of Medicine and Pharmacology and Toxicology (Y.J.K.), University of Louisville School of Medicine, KY; and Department of Genetics and Medical Genetics (T.A.P.), University of...
ORCID: Dai, Dao-Fu
Johnson, Simon C.
Chin, Michael T.
Chen, Tony
Marcinek, David J.
Dorn, Gerald W.
Kang, Y. James
Santana, Luis F.
Rabinovitch, Peter S.
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-04
Volume: 108
Issue: 7
Pages: 837-846
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.110.232306
PMC: PMC3785241
OpenAlex: W2117205119
Cited by: 527
References: 35
Citations by year: 2026: 14 · 2025: 35 · 2024: 30 · 2023: 32 · 2022: 28 · 2021: 42 · 2020: 46 · 2019: 34 · 2018: 31 · 2017: 29 · 2016: 44 · 2015: 34 · 2014: 37 · 2013: 36 · 2012: 41
FWCI: 16.21
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (AG001751, AG013280)
National Institute on Aging (AG-028455, AG001751, P01AG001751, AG013280, AG035844, RC1AG035844, R01AG028455, P30AG013280)
National Heart, Lung, and Blood Institute (R01HL101186, HL-101186, R01HL063760, HL063760, R01HL059888)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: mitochondrial oxidative stress, reactive oxygen species, angiotensin II, cardiac hypertrophy, heart failure, catalase, mitochondrial DNA damage, mitochondrial DNA deletions, autophagy, mitochondrial biogenesis, hypertensive cardiomyopathy, myocardial fibrosis, zidovudine, mitochondria-targeted antioxidants
MeSH terms: Angiotensin II, Animals, Catalase, DNA Damage, DNA, Mitochondrial, Gene Expression Regulation, Cardiomegaly, Heart Failure, Mice, Transgenic, Mitochondria, Heart, Zidovudine, Reactive Oxygen Species, Oxidative Stress, Reverse Transcriptase Inhibitors, Models, Animal, Myocytes, Cardiac, GTP-Binding Protein alpha Subunits, Gq-G11, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks